Overview

Gender

male

Marc joined AstraZeneca in June 2013 as Executive Vice-President, Global Portfolio & Product Strategy before being appointed as an Executive Director and Chief Financial Officer in November 2013. In this role he is responsible for Finance and Investor Relations. Marc is also responsible for AstraZeneca's business in Japan.

A French national with a background in finance and accounting, Marc Dunoyer began his career in the pharmaceutical industry at Roussel Uclaf in Paris in the 1970s before becoming President, Japan and then President, Asia Pacific. After returning to France for a period as Managing Director, Global Pharmaceuticals Division, in the 1990s, Marc was appointed President & CEO, Asia Pacific & Japan for Hoechst Marion Roussel in 1995. In 2000, he joined Glaxo Wellcome − just ahead of the merger that created GlaxoSmithKline − as Regional President, Japan and subsequently Regional President, Asia Pacific & Japan.

His most recent role before joining AstraZeneca was Global Head of Rare Diseases and (concurrently) Chairman, GSK Japan. Marc has an MBA from the Hautes Études Commerciales and a Bachelor of Law degree from Paris University. He qualified as a Junior Certified Public Accountant in France.